Actively Recruiting
Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care
Led by Centre Hospitalier Universitaire de Besancon · Updated on 2024-09-19
150000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study focuses on patients admitted to medical and surgical intensive care units, aiming to understand how transfusion practices affect their morbidity and mortality. Researchers are collecting data to correlate transfusion monitoring with patient outcomes, which could help guide future transfusion recommendations outside of critical emergencies and intensive care. The study will observe actual transfusion monitoring during the ICU stay, the period following ICU discharge, and after hospital discharge. It aims to gather comprehensive information on transfusion practices over these phases without introducing any interventions. Participants will be monitored for survival up to 90 days after leaving the ICU. Data collection includes evaluating transfusion monitoring and its relation to patient prognosis. This long-term follow-up will help assess the impact of transfusion practices on patient outcomes after intensive care and hospitalization, with total participation duration varying per individual.
CONDITIONS
Brief Title
Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient admitted to medical and surgical resuscitation units of Besan�e7on and Dijon university hospitals, all causes considered
- Patient admitted between 1st January 2012 to 31st December 2017
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 years depending on admission date
Participants who undergo routine care in intensive care units are observed to assess outcomes related to transfusional practices.
Survival assessed at 90 days after leaving ICU
Trial Site Locations
Total: 1 location
1
CHU de Besançon
Besançon, France
Actively Recruiting
Research Team
M
Maxime Desmarets, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here